Decreased active GLP-1 response following large test meal in patients with type 1 diabetes using bolus insulin analogues

Endocrine Journal

Volumn 58, Issue 10, 2011, Pages 905-911

  Kamoi, Kyuzi ^a,d   Shinozaki, You ^a,b   Furukawa, Kazuo ^a,b   Sasaki, Hideo ^c  

^a NAGAOKA RED CROSS HOSPITAL   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c Niigata Medical Center   (Japan)

^d UNIVERSITY OF NIIGATA PREFECTURE   (Japan)

Author keywords

Active glucagon like peptide 1; C peptide immunoreactivity; Insulin; Test meal; Type 1 diabetes mellitus

Indexed keywords

C PEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; INSULIN DERIVATIVE;

ADULT; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; JAPANESE; MALE; PROTEIN BLOOD LEVEL; TEST MEAL;

BIPHASIC INSULINS; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, SHORT-ACTING; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD;

EID: 80055066799     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K11E-125     Document Type: Article

References (15)

1. Kieffer TJ, McIntosh CH, Pederson RA (1995) Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136: 3585-3596.
2. Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ (2003) Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab 88: 2706-2713.
3. World Health Organization (1999) Definition, diagnosis and classification of diabetes and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: Department of Noncommunicable Disease Surveillance.
4. Vahl TP, Paty BW, Fuller BD, Prigeon RL, D'Alessio DA (2003) Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1-(9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans. J Clin Endocrinol Metab 88: 1772-1779.
5. Kasezawa N, Shinzato M, Maruyama N, Takeyoshi U, Kobayashi S, Shimamune Y, Sekino T, Sakai Y, Katagiri T, Izu K, Arai O, Kaneko K, Kamoi K (1987) Development of rapid automated simultaneous measurements of stable and labile glycosylated hemoglobins and fetal hemoglobin by high performance liquid chromatography and studies on the clinical evaluation. Rinsho Byori 35: 203-210 (in Japanese).
6. American Diabetes Association (2011) Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 34(Supplement 1): S62-S69.
7. Lugari R, Dell'Anna C, Ugolotti D, Dei Cas A, Barilli AL, Zandomeneghi R, Marani B, Iotti M, Orlandini A, Gnudi A (2000) Effect of nutrient ingestion on glucagon-like peptide 1 (7-36 amide) secretion in human type 1 and type 2 diabetes. Horm Metab Res 32: 424-428.
8. Mannucci E, Pala L, Ciani S, Bardini G, Pezzatini A, Sposato I, Cremasco F, Ognibene A, Rotella CM (2005) Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus. Diabetologia 48: 1168-1172.
9. Ryskjaer J, Deacon CF, Carr RD, Krarup T, Madsbad S, Holst J, Vilsbøll T (2006). Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake. Eur J Endocrinol 155: 485-493.
10. Hare KJ, Vilsbøll T, Holst JJ, Knop FK (2010) Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 298: E832-E837.
11. Bilodeau N, Fiset A, Poirier GG, Fortier S, Gingras MC, Lavoie JN, Faure RL (2006) Insulin-dependent phosphorylation of DPP IV in liver. Evidence for a role of compartmentalized c-Src. FEBS J 273: 992-1003.
12. Varga T, Firneisz G, Nagy G, Somogyi A (2010) Elevated serum dipeptidyl peptidase-4 activity in type 1 diabetes mellitus: a direct comparison. Orv Hetil 151: 899-902.
13. Creutzfeldt W, Talaulicar M, Ebert R, Willms B (1980) Inhibition of gastric inhibitory polypeptide (GIP) release by insulin and glucose in juvenile diabetes. Diabetes 29: 140-145.
14. Matsuyama T, Hoffman WH, Dunbar JC, Foà NL, Foà PP (1975) Glucose, insulin, pancreatic glucagon and glucagon-like immunoreactive materials in the plasma of normal and diabetic children. Effect of the initial insulin treatment. Horm Metab Res 7: 452-456.
15. Shigeto M, Katsura M, Matsuda M, Ohkuma S, Kaku K (2008) Low, but physiological, concentration of GLP-1 stimulates insulin secretion independent of the cAMPdependent protein kinase pathway. J Pharmacol Sci 108: 274-279.